gsidgsidgsid
Welcome to the Global Solutions For Infectious Diseases Website
GSID Home Page
About Us
Our Programs
Support GSID
News & Publications
Contact Us
header

AIDSVAX® Research Collaborators

Following its mission, GSID has established numerous research collaborations with researchers from both the public and private sectors and academia around the world. We serve as investigational product sponsors by providing AIDSVAX® vaccine to clinical trial sponsors, such as the USMHRP and the NIH. We also collaborate by providing our vaccine, rgp120 reagents, serological specimens and clinical study data to other researcher who are planning the next large-scale HIV vaccine efficacy trials, developing the next generation of HIV vaccines or conduction experiments to better understand why AIDSVAX® B/E was prominent in the partial efficacy demonstrated in RV 144.

If you are interested in collaborating with GSID on our AIDSVAX research, please follow the directions here.

AIDSVAX® Research Collaborations

No.
Collaborating Institution
Investigator(s)
Type of Collaboration
1
Armed Forces Research Institute for Medical Sciences (AFRIMS)*
o'Connell, Karasawa, Excler, et.al.
vaccine, rgp 120 reagents, serological specimens
2
CHUV (Centre Hospitalier Universitaire Vadois)*
Pantaleo
clinical study, vaccine
3
Dartmouth College
Ackerman
serological  specimens
4
Duke University, Department of Medicine, Human Vaccine Institute
Haynes, Montefiori, Tomares, Moody, et.al.
rgp 120 reagents, serological specimens, clinical study
5
EuroVacc Foundation*
Pantaleo
clinical studies, vaccine
6
Fred C. Hutchinson Cancer Research Center*
Gilbert, McElrath, Frahm
clinical study data,rgp 120  reagents
7
GeoVax (private sector company)
Robinson
clinical study
8
Harvard University/Beth Israel Deaconess Medical Center*
Barouch, Shanta
vaccine
9
HIV Vaccine Trials Network (HVTN)*
Various
clinical studies
10
International AIDS Vaccine Initiative (IAVI)
Priddy
clinical study
11
Immunetics (private sector company)*
Levine
serological specimens
12
iPox Foundation*
Pantaleo
clinical studies
13
Joan & Sanford I. Weil Medical College of Cornell University
Moore
rgp 120 reagents, serological specimens
14
Los Alamos National Lab
Korber
serological specimens
15
Massachusetts General Hospital (Ragon Institute)*
Alter
serological specimens
16
Massachusetts Institute of Technology
Lowe
serological specimens
17
National Institutes of Health (NIH) / National Institute of Allergy and Infectious Diseases (NIAID) / Division of AIDS (DAIDS)*
Various
clinical studies,  serological specimens
18
NIH / NIAID -Vaccine Research Center*
Koup, Bailer, Anthos Wyatt, Mascola
rgp 120 reagents, serological specimens
19
NIH - Biostatistics Research Branch of the Division of Clinical Research
Follmann
clinical study data
20
New York University Langone School of Medicine*
Zolla-Pazner, Marmor, Cardozo
serological specimens, clinical study data
21
New York University/Veteran's Administration New York Harbor Healthcare System*
Hioe
rgp 120 reagents, serological specimens
22
PaxVax (private sector company)
Gurwith, Connors
clinical study
23
Rockefeller University/Howard Hughes Medical Institute
Neuaezweig
vaccine
24
Rush University Medical Center
Baum
rgp 120 reagents
25
San Francisco Department of Public Health
Buchbinder
clinical study data
26
Sanofi Pasteur (private sector company)*
Tartaglia, Phogat, et.al.
clinical studies
27
SRI International
Wang
serological samples
28
Tulane University
Weazy
vaccine
29
University of Alabama, Birmingham*
Shaw, Hahn, Bar
serological specimens
30
University of California, Irvine*
Forthal
rgp 120 reagents
31
University of California, San Francisco*
Wittington
clinical study data
32
University of California, Santa Cruz*
Berman
rgp 120 reagents, serological specimens
33
University of Kansas
Desaire
rgp 120 reagents
34
University of Maryland, Baltimore
DeVico
vaccine, serological specimens
35
University of Melbourne
Kent
rgp 120 reagents
36
University of Nebraska, Lincoln*
Li
vaccine, rgp 120 reagents
37
University of North Carolina, Charlotte
Sun
clinical study data
38
University of Pennsylvania*
Shaw, Hahn, Bar
serological specimens
39
University of Washington
Greenberg, Goodreau
vaccine, clinical study data
40
US Food & Drug Administration
Krause
vaccine
41
US Military HIV Research Program (MHRP) and Walter Reed Army Institute of Research (WRAIR)*
Michael, Kim, Robb, et.al.
clinical studies, vaccine, rgp 120 reagents, serological specimens
42
Vanderbilt University
Crowe
serological specimens
43
University of Rochester
Johnson
Clinical study data
44
University of JAEN (Spain)
Caruzo
Clinical study data
* With these institutions, GSID has entered into multiple cooperative research and development, clinical trial and material transfer agreements.

 

Additional Resources



 

 


GSID to support four new AIDSVAX® B/E clinical trials in 2017
[more]